Nyumbani › Limfadenopati ya Immunoblastic › Michigan
Majaribio ya kliniki ya Limfadenopati ya Immunoblastic katika jimbo la Michigan
Masomo 4 ya Limfadenopati ya Immunoblastic yanatafuta washiriki katika vituo vya jimbo la Michigan.
Miji katika jimbo la Michigan
Maandishi rasmi ya utafiti (Kiingereza)
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT04803201Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- Roger Cancer Center University of Michigan Health, Ann Arbor
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06561048A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
- Clinical Trial Site, Detroit
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06393738Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- University of Michigan, Ann Arbor
- Barbara Ann Karmanos Cancer Institute Wayne State University, Detroit
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2025 · NCT04234048Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.